About this FactMed analysis covering adverse side effect reports of ACETASOL patients who developed ARTERIOSCLEROSIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking ACETASOL reported ARTERIOSCLEROSIS to the FDA. A total of 32 ACETASOL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ACETASOL and ARTERIOSCLEROSIS. In doing so, we compare ACETASOL with other drugs that cause ARTERIOSCLEROSIS, to help you evaluate whether or not ACETASOL causes ARTERIOSCLEROSIS. Likewise, this page shows the most highly-reported side effects of ACETASOL, so you can see if ARTERIOSCLEROSIS ranks among ACETASOL's most well-known side effects.
Summary Statistics
Reports of ACETASOL causing ARTERIOSCLEROSIS: 1
Reports of any side effect of ACETASOL : 32
Percentage of ACETASOL patients where ARTERIOSCLEROSIS is a reported side effect: 3.1250%

FDA reports of any drug causing ARTERIOSCLEROSIS : 6130
Average percentage for all medicated patients where ARTERIOSCLEROSIS is reported as a complication: 0.0384%

Physician opinion on ACETASOL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ACETASOL:
EAR INFECTION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with ARTERIOSCLEROSIS:

VIOXX (2243 patients)
ASPIRIN (1386 patients)
FOSAMAX (1311 patients)
AVANDIA (887 patients)
ZOMETA (848 patients)
LIPITOR (665 patients)
AREDIA (647 patients)
LASIX (559 patients)
LISINOPRIL (529 patients)
PLAVIX (449 patients)
HEPARIN SODIUM INJECTION (440 patients)
PRILOSEC (411 patients)
ZOCOR (410 patients)
FUROSEMIDE (410 patients)
PROTONIX (402 patients)
COUMADIN (387 patients)
PREDNISONE (375 patients)
CELEBREX (374 patients)
DIGOXIN (341 patients)
SEROQUEL (326 patients)
NEURONTIN (320 patients)
ZOLOFT (314 patients)
AMBIEN (311 patients)
TOPROL-XL (310 patients)
NORVASC (304 patients)
NEXIUM (299 patients)
ATENOLOL (296 patients)
SIMVASTATIN (293 patients)
SYNTHROID (287 patients)
PREVACID (260 patients)
POTASSIUM CHLORIDE (258 patients)
NITROGLYCERIN (256 patients)
HYDROCHLOROTHIAZIDE (250 patients)
FOLIC ACID (239 patients)
LEVAQUIN (237 patients)
VICODIN (232 patients)
WARFARIN SODIUM (232 patients)
PERCOCET (221 patients)
XANAX (219 patients)
OXYCONTIN (219 patients)
LOPRESSOR (219 patients)
PREMARIN (218 patients)
GLUCOPHAGE (212 patients)
ALBUTEROL (211 patients)
VITAMIN D (208 patients)
ACETAMINOPHEN (203 patients)
METOPROLOL TARTRATE (203 patients)
LORTAB (200 patients)
ALLOPURINOL (199 patients)
OMEPRAZOLE (197 patients)
DURAGESIC-100 (197 patients)
COREG (197 patients)
INSULIN (195 patients)
ATIVAN (192 patients)
DEXAMETHASONE (188 patients)
LANTUS (188 patients)
LORAZEPAM (184 patients)
LEVOTHYROXINE SODIUM (181 patients)
METFORMIN HCL (181 patients)
AVANDAMET (172 patients)
REGLAN (168 patients)
CALCIUM (167 patients)
MORPHINE (167 patients)
ZOFRAN (167 patients)
ACTOS (163 patients)
DIOVAN (162 patients)
MULTI-VITAMINS (162 patients)
LOVENOX (161 patients)
CRESTOR (161 patients)
PROCRIT /00909301/ (160 patients)
ACCUTANE (159 patients)
ZETIA (159 patients)
OXYCODONE HCL (155 patients)
CLINDAMYCIN (154 patients)
CHEMOTHERAPEUTICS NOS (153 patients)
AMOXICILLIN (151 patients)
THALIDOMIDE (151 patients)
WELLBUTRIN (150 patients)
CIPROFLOXACIN (149 patients)
METOPROLOL (148 patients)
ARANESP (148 patients)
ADVAIR DISKUS 100/50 (148 patients)
COZAAR (148 patients)
CEPHALEXIN (147 patients)
COLACE (147 patients)
PAXIL (147 patients)
IBUPROFEN (146 patients)
FLEXERIL (144 patients)
ALTACE (144 patients)
FLOMAX (143 patients)
ZYRTEC (143 patients)
ZYPREXA (142 patients)
KLOR-CON (142 patients)
GABAPENTIN (140 patients)
PROZAC (140 patients)
TAMOXIFEN CITRATE (139 patients)
CYMBALTA (139 patients)
FEMARA (139 patients)
TYLENOL (CAPLET) (135 patients)
SANDOSTATIN LAR (134 patients)
VITAMIN E (133 patients)
GLYBURIDE (131 patients)
LEXAPRO (130 patients)
TAXOTERE (130 patients)
BEXTRA (130 patients)
ZITHROMAX (130 patients)
EFFEXOR (128 patients)
DECADRON (128 patients)
AMARYL (126 patients)
[THERAPY UNSPECIFIED] (126 patients)
MORPHINE SULFATE (126 patients)
AUGMENTIN '125' (125 patients)
HUMALOG (125 patients)
ASCORBIC ACID (124 patients)
LYRICA (124 patients)
KEFLEX (124 patients)
PREDNISONE TAB (122 patients)
ZANTAC (122 patients)
CLONIDINE (122 patients)
CALCIUM CARBONATE (120 patients)
HYDROCODONE BITARTRATE (117 patients)
PERIDEX (117 patients)
VYTORIN (116 patients)
ALENDRONATE SODIUM (114 patients)
NASONEX (112 patients)
CELEXA (112 patients)
ACCUPRIL (111 patients)
PEPCID (111 patients)
VITAMIN B-12 (111 patients)
CARDIZEM (109 patients)
DILAUDID (109 patients)
PREDNISOLONE (109 patients)
FASLODEX (108 patients)
LANOXIN (108 patients)
ZESTRIL (108 patients)
RESTORIL (107 patients)
MEGACE (106 patients)
RADIATION THERAPY (106 patients)
VITAMINS (UNSPECIFIED) (104 patients)
TRAZODONE HCL (104 patients)
HEPARIN SODIUM (104 patients)
TRICOR (103 patients)
ALPRAZOLAM (102 patients)
FENTANYL (102 patients)
ELAVIL (102 patients)
COMPAZINE (102 patients)
PROMETHAZINE (101 patients)
GLIPIZIDE (101 patients)
REMERON (101 patients)
SINGULAIR (101 patients)
MAGNESIUM (101 patients)
HEPARIN (101 patients)
ALLEGRA (100 patients)
VELCADE (99 patients)
VIAGRA (98 patients)
METFORMIN (98 patients)
PRAVACHOL (97 patients)
NAPROXEN (96 patients)
HERCEPTIN (95 patients)
SPIRONOLACTONE (95 patients)
PREMPRO (95 patients)
VANCOMYCIN (93 patients)
AMLODIPINE (93 patients)
ULTRAM (92 patients)
FLAGYL (92 patients)
LUPRON (91 patients)
AVONEX (91 patients)
TEMAZEPAM (90 patients)
DARVOCET-N 50 (90 patients)
RISPERDAL (88 patients)
HUMIRA (88 patients)
DIAZEPAM (88 patients)
TRAMADOL HCL (88 patients)
NAVELBINE (87 patients)
XELODA (87 patients)
CLONAZEPAM (87 patients)
FORTEO (86 patients)
ATROVENT (85 patients)
FAMOTIDINE (84 patients)
ARIMIDEX (84 patients)
ENALAPRIL MALEATE (84 patients)
BENADRYL (84 patients)
GLUCOTROL (83 patients)
MS CONTIN (83 patients)
ACTONEL (83 patients)
ALDACTONE (83 patients)
SOMA (82 patients)
LOVASTATIN (80 patients)
FERROUS SULFATE TAB (80 patients)
CALCIUM (UNSPECIFIED) (80 patients)
DOXYCYCLINE (79 patients)
MOTRIN (79 patients)
ACIPHEX (78 patients)
CIPRO (77 patients)
MULTI-VITAMIN (77 patients)
POTASSIUM (77 patients)
REVLIMID (77 patients)
CHLORHEXIDINE GLUCONATE (77 patients)
METRONIDAZOLE (77 patients)
CARBOPLATIN (76 patients)
RANITIDINE (76 patients)
EPOGEN (76 patients)
RAMIPRIL (75 patients)
PROVERA (75 patients)
VASOTEC (75 patients)
METHOTREXATE (74 patients)
TYLENOL (74 patients)
SPIRIVA (73 patients)
NAPROSYN (73 patients)
TASIGNA (73 patients)
Most common side effects for patients taking ACETASOL:
ANTIPHOSPHOLIPID SYNDROME (20 patients)
PERICARDITIS (20 patients)
PLEURISY (20 patients)
PULMONARY EMBOLISM (20 patients)
SYSTEMIC LUPUS ERYTHEMATOSUS (20 patients)
COLLAPSE OF LUNG (13 patients)
FALL (9 patients)
EMPHYSEMA (8 patients)
HAEMOPTYSIS (8 patients)
HEPATIC STEATOSIS (8 patients)
HEPATOMEGALY (8 patients)
POST PROCEDURAL COMPLICATION (8 patients)
RED BLOOD CELL COUNT DECREASED (8 patients)
RESPIRATORY DISTRESS (8 patients)
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED (4 patients)
ANTINUCLEAR ANTIBODY POSITIVE (4 patients)
ANTIPHOSPHOLIPID ANTIBODIES POSITIVE (4 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (4 patients)
BLOOD PRESSURE DECREASED (4 patients)
BLOOD UREA DECREASED (4 patients)
FLUID OVERLOAD (4 patients)
HEART RATE INCREASED (4 patients)
MYOCARDIAL INFARCTION (4 patients)
PROCEDURAL COMPLICATION (4 patients)
BLOOD CHOLESTEROL INCREASED (3 patients)
CEREBROVASCULAR ACCIDENT (3 patients)
COUGH (3 patients)
DEPRESSION (3 patients)
DYSPEPSIA (3 patients)
URINARY TRACT INFECTION (3 patients)
ACUTE MYOCARDIAL INFARCTION (2 patients)
ASTHENIA (2 patients)
CARDIAC FAILURE CONGESTIVE (2 patients)
CYSTITIS (2 patients)
DEHYDRATION (2 patients)
DIABETES MELLITUS NON-INSULIN-DEPENDENT (2 patients)
DISEASE RECURRENCE (2 patients)
DIZZINESS (2 patients)
ERYTHEMA (2 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (2 patients)
HEPATIC CIRRHOSIS (2 patients)
HICCUPS (2 patients)
HYPOTHYROIDISM (2 patients)
INFLUENZA (2 patients)
ISCHAEMIC STROKE (2 patients)
NAUSEA (2 patients)
SLEEP DISORDER (2 patients)
STAPHYLOCOCCAL INFECTION (2 patients)
VISUAL DISTURBANCE (2 patients)
VOMITING (2 patients)
WEIGHT DECREASED (2 patients)
WEIGHT INCREASED (2 patients)
ABDOMINAL SEPSIS (1 patients)
ACUTE ABDOMEN (1 patients)
ACUTE RESPIRATORY FAILURE (1 patients)
AFFECT LABILITY (1 patients)
ANXIETY (1 patients)
AORTIC VALVE SCLEROSIS (1 patients)
ARTERIOSCLEROSIS (1 patients)
ARTERIOVENOUS FISTULA OPERATION (1 patients)
ASCITES (1 patients)
ATRIOVENTRICULAR BLOCK FIRST DEGREE (1 patients)
BACK PAIN (1 patients)
BACTERIAL INFECTION (1 patients)
BALANCE DISORDER (1 patients)
BLINDNESS (1 patients)
BLOOD PRESSURE INCREASED (1 patients)
BLOOD TRIGLYCERIDES INCREASED (1 patients)
BRONCHIAL OBSTRUCTION (1 patients)
BUNDLE BRANCH BLOCK LEFT (1 patients)
CARDIOVASCULAR DISORDER (1 patients)
CAROTID ARTERY DISEASE (1 patients)
CEREBRAL ATROPHY (1 patients)
CEREBRAL INFARCTION (1 patients)
CERUMEN IMPACTION (1 patients)
CHEYNE-STOKES RESPIRATION (1 patients)
CONSTIPATION (1 patients)
CONVULSION (1 patients)
CORONARY ARTERY DISEASE (1 patients)
CORONARY ARTERY STENOSIS (1 patients)
DEAFNESS NEUROSENSORY (1 patients)
DEEP VEIN THROMBOSIS (1 patients)
DERMATITIS (1 patients)
DIABETES MELLITUS (1 patients)
DIFFICULTY IN WALKING (1 patients)
DISORIENTATION (1 patients)
DISTURBANCE IN ATTENTION (1 patients)
DIVERTICULUM DUODENAL (1 patients)
DRUG INEFFECTIVE (1 patients)
DYSPNOEA EXERTIONAL (1 patients)
DYSSTASIA (1 patients)
EAR INFECTION (1 patients)
EYE INFECTION (1 patients)
EYE IRRITATION (1 patients)
FEELING HOT (1 patients)
FOOT FRACTURE (1 patients)
GALLBLADDER DISORDER (1 patients)
GASTRITIS (1 patients)
GRAND MAL CONVULSION (1 patients)
GROIN INFECTION (1 patients)
HERNIA (1 patients)
HYPERSENSITIVITY (1 patients)
INFECTION (1 patients)
INSOMNIA (1 patients)
INTESTINAL INFARCTION (1 patients)
IRRITABLE BOWEL SYNDROME (1 patients)
LIBIDO DECREASED (1 patients)
MENTAL STATUS CHANGES (1 patients)
MITRAL VALVE INCOMPETENCE (1 patients)
MITRAL VALVE SCLEROSIS (1 patients)
MYALGIA (1 patients)
NASAL CONGESTION (1 patients)
NEPHROLITHIASIS (1 patients)
NON-CARDIAC CHEST PAIN (1 patients)
OEDEMA (1 patients)
OSTEOARTHRITIS (1 patients)
OSTEOPENIA (1 patients)
PARATHYROID DISORDER (1 patients)
PERITONITIS (1 patients)
POLYARTHRITIS (1 patients)
PROCTITIS (1 patients)
PULMONARY HYPERTENSION (1 patients)
RASH (1 patients)
RESPIRATORY FAILURE (1 patients)
RHINITIS ALLERGIC (1 patients)
ROAD TRAFFIC ACCIDENT (1 patients)
SEPTIC SHOCK (1 patients)
SINUSITIS (1 patients)
SKIN INFECTION (1 patients)
SLEEP APNOEA SYNDROME (1 patients)
SOMNOLENCE (1 patients)
STENT OCCLUSION (1 patients)
TRANSIENT ISCHAEMIC ATTACK (1 patients)
TRICUSPID VALVE INCOMPETENCE (1 patients)
VASCULAR PSEUDOANEURYSM (1 patients)
VERTIGO (1 patients)
WOUND INFECTION PSEUDOMONAS (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ACETASOL


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about ARTERIOSCLEROSIS and ACETASOL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ACETASOL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ACETASOL. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ACETASOL experts. If you are a healthcare provider experienced in prescribing ACETASOL, please register here.
giCould not connect: